ED
ERAS icon

Exane Derivatives’s Erasca ERAS Stock Holding History

Exane Derivatives’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$80.1K Buy
+14,377
New +$94.1K 0.05% 283
2022
Q1 		– Sell
-5,589
Closed -$87.1K – 1037
2021
Q4 		$87.1K Buy
+5,589
New +$95.7K 0.02% 450

Other funds holding ERAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Exane Derivatives's ERAS Position: Q2 2022 in Review

Exane Derivatives opened a new position in Erasca (ERAS) in Q2 2022: 14,377 shares worth $80.1K. The stake represents 0.05% of the portfolio and ranks #283 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in ERAS as recently as Q4 2021.

Exane Derivatives first reported a position in ERAS in Q4 2021 and has held it in 2 quarters since. The position peaked at $87.1K in Q4 2021. 89 funds tracked by Wall St. Rank hold ERAS as of Q2 2022.

  • Exane Derivatives held 14,377 shares of Erasca worth $80.1K as of Q2 2022.
  • Erasca was a new Exane Derivatives position in Q2 2022.
  • Erasca made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #283 holding.
  • Exane Derivatives first reported a position in Erasca in Q4 2021 and has held it in 2 quarters since.
  • Exane Derivatives's Erasca position peaked at $87.1K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Erasca as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.